Serum homovanillic acid levels in schizophrenic patients and normal control subjects

Psychiatry Res. 1993 Aug;48(2):93-106. doi: 10.1016/0165-1781(93)90034-e.

Abstract

Schizophrenic patients with an early age at onset of illness had low baseline levels of homovanillic acid (HVA) in serum compared with schizophrenic patients with a late age at onset. After adjustments were made for age at onset, there was a significant partial correlation between positive symptoms and serum HVA. The relationship between positive symptom scores and serum HVA was shifted to the left in the early onset patients, suggesting a relatively increased sensitivity of dopamine-associated response. Patients with severe negative symptoms also had an earlier age at onset and a trend toward lower serum HVA. This study found no difference between mean serum HVA values in schizophrenic patients and normal control subjects.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Homovanillic Acid / blood*
  • Humans
  • Male
  • Psychiatric Status Rating Scales
  • Reference Values
  • Schizophrenia / blood*
  • Schizophrenic Psychology*

Substances

  • Homovanillic Acid